Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST® T1)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST® T1)

Published:2016-02-19 Issue:2 Volume:34 Page:167-173
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Hirsch I. B.¹,Franek E.²,Mersebach H.³,Bardtrum L.⁴,Hermansen K.⁵

Affiliation:

1. School of Medicine; University of Washington; Seattle WA USA

2. Mossakowski Medical Research Centre; Polish Academy of Sciences and Department of Internal Diseases, Endocrinology and Diabetology; Central Clinical Hospital MSW; Warsaw Poland

3. Novo Nordisk Inc.; Princeton NJ USA

4. Novo Nordisk A/S; Søborg Denmark

5. Aarhus University Hospital; Aarhus Denmark

Funder

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.13068/fullpdf

Reference28 articles.

1. Insulin degludec aspart: the first co-formulation of insulin analogues;Kalra;Diabetes Ther Res Treat Educ Diabetes Relat Disord,2014

2. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry;Weinstock;J Clin Endocrinol Metab,2013

3. Correlates of insulin injection omission;Peyrot;Diabetes Care,2010

4. Brief report: the burden of diabetes therapy: implications for the design of effective patient-centered treatment regimens;Vijan;J Gen Intern Med,2005

5. The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin;Cengiz;Diabetes Care,2012

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initiation or switch to insulin degludec/insulin aspart in adults with type 2 diabetes in India: Results from a prospective, non-interventional, real-world study;Journal of Family Medicine and Primary Care;2024-09

2. Initiating or switching to insulin degludec/insulin aspart in a real‐world population of adults with type 2 diabetes in Australia: results from a prospective, non‐interventional study;Internal Medicine Journal;2024-08-22

3. Improvement in Glycemic Indices and Point in Range by Addition or Switch to IDegAsp–Real-World Evidence;Journal of Diabetology;2024-07

4. Insulin;Pharmaceutical Biotechnology;2024

5. Initiating or switching to IDegAsp in a real-world South African population with type 2 diabetes – a cohort analysis from the ARISE study;Journal of Endocrinology, Metabolism and Diabetes of South Africa;2023-05-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3